AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 271: R200-R207, 1996;
0363-6119/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Q.
Right arrow Articles by Blaine, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Q.
Right arrow Articles by Blaine, E. H.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 1 200-R207, Copyright © 1996 by American Physiological Society


ARTICLES

Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency

Q. Li, W. E. Dale, E. M. Hasser and E. H. Blaine
Dalton Cardiovascular Research Center, University of Missouri, Columbia 65211, USA.

We examined the mechanisms mediating hypertension in conscious rats during acute and chronic infusion of angiotensin II (ANG II) at pressor doses (50, 100, and 200 ng.kg-1.min-1). Trimethaphan-induced blood pressure reduction was inversely related to the acute dose of ANG II, consistent with a constrictor action of ANG II on vascular smooth muscle and withdrawal of sympathetic tone. During chronic ANG II infusion, the entire increase in mean arterial pressure (MAP) was inhibited by trimethaphan, consistent with neural mediation. During acute ANG II hypertension, the AT1-specific receptor blocker losartan induced a large fall in MAP (64 +/- 4 mmHg) in ganglion-blocked (chlorisondamine) rats, whereas, during chronic ANG II hypertension, losartan had only a small hypotensive effect (11 +/- 3 mmHg). To determine the time course of the change from vascular smooth muscle action to neural action, we measured MAP in response to trimethaphan during the first 24 h of ANG II infusion. After 5 h, the minimal MAP in response to trimethaphan was significantly higher than that before ANG II. After 10 h of infusion, trimethaphan decreased MAP to pre-ANG II levels. That is, the neural component was fully active after only 10 h of infusion in rats. Finally, chronic administration of ANG II resulted in a dose-related increase in MAP that, at all doses, was completely inhibited by trimethaphan. These findings are consistent with ANG II acting primarily on vascular smooth muscle during acute infusion and via neural pathways during chronic treatment. The transition from direct smooth muscle to indirect neural action is rapid in rats (< 10 h), and the MAP and neural responses to ANG II are dose related during chronic hypertension.


This article has been cited by other articles:


Home page
HypertensionHome page
S. L. Burke, R. G. Evans, J.-L. Moretti, and G. A. Head
Levels of Renal and Extrarenal Sympathetic Drive in Angiotensin II-Induced Hypertension
Hypertension, April 1, 2008; 51(4): 878 - 883.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
F. D. McBryde, S.-J. Guild, C. J. Barrett, J. W. Osborn, and S. C. Malpas
Cardiovascular Control: Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits
Exp Physiol, September 1, 2007; 92(5): 831 - 840.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. G. Evans, S. L. Burke, G. W. Lambert, and G. A. Head
Renal responses to acute reflex activation of renal sympathetic nerve activity and renal denervation in secondary hypertension
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1247 - R1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. G. Hood, T. Cochrane, M. J. McKinley, and C. N. May
Investigation of the mechanisms by which chronic infusion of an acutely subpressor dose of angiotensin II induces hypertension
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1893 - R1899.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. L. Burke, G. A. Head, G. W. Lambert, and R. G. Evans
Renal Sympathetic Neuroeffector Function in Renovascular and Angiotensin II-Dependent Hypertension in Rabbits
Hypertension, April 1, 2007; 49(4): 932 - 938.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. B. Nahey and J. P. Collister
ANG II-induced hypertension and the role of the area postrema during normal and increased dietary salt
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H694 - H700.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. D. Giraud, J. J. Faber, S. Jonker, L. Davis, and D. F. Anderson
Intravascular infusions of plasma into fetal sheep cause arterial and venous hypertension
J Appl Physiol, September 1, 2005; 99(3): 884 - 889.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. J. Barrett, S.-J. Guild, R. Ramchandra, and S. C. Malpas
Baroreceptor Denervation Prevents Sympathoinhibition During Angiotensin II-Induced Hypertension
Hypertension, July 1, 2005; 46(1): 168 - 172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Xue, J. Pamidimukkala, and M. Hay
Sex differences in the development of angiotensin II-induced hypertension in conscious mice
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2177 - H2184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. W. Osborn, F. Jacob, and P. Guzman
A neural set point for the long-term control of arterial pressure: beyond the arterial baroreceptor reflex
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R846 - R855.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. D. Stocker, K. J. Keith, and G. M. Toney
Acute inhibition of the hypothalamic paraventricular nucleus decreases renal sympathetic nerve activity and arterial blood pressure in water-deprived rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R719 - R725.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. C. Malpas
What sets the long-term level of sympathetic nerve activity: is there a role for arterial baroreceptors?
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R1 - R12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Osborn, P. Ariza-Nieto, J. P. Collister, S. Soucheray, B. Zimmerman, and S. Katz
Responsiveness vs. basal activity of plasma ANG II as a determinant of arterial pressure salt sensitivity
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2142 - H2149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Xue, H. Gole, J. Pamidimukkala, and M. Hay
Role of the area postrema in angiotensin II modulation of baroreflex control of heart rate in conscious mice
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H1003 - H1007.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Bealer
Increased dietary sodium alters neural control of blood pressure during intravenous ANG II infusion
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H559 - H565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Xu and A. F. Sved
Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R451 - R459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. G. Sanderford and V. S. Bishop
Central mechanisms of acute ANG II modulation of arterial baroreflex control of renal sympathetic nerve activity
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1592 - H1602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. G. Sanderford and V. S. Bishop
Angiotensin II acutely attenuates range of arterial baroreflex control of renal sympathetic nerve activity
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1804 - H1812.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. S. Pachori, H. Wang, C. H. Gelband, C. M. Ferrario, M. J. Katovich, and M. K. Raizada
Inability to Induce Hypertension in Normotensive Rat Expressing AT1 Receptor Antisense
Circ. Res., June 9, 2000; 86(11): 1167 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. L. Bealer
Preoptic recess noradrenergic receptors control modification of baroreflex sensitivity by hypertonicity
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R44 - R51.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Li, M. J. Sullivan, W. E. Dale, E. M. Hasser, E. H. Blaine, and J. T. Cunningham
Fos-Like Immunoreactivity in the Medulla after Acute and Chronic Angiotensin II Infusion
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1165 - 1173.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Collister and J. W. Osborn
Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R357 - R366.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Casellas, N. Bouriquet, and A. Herizi
Bosentan Prevents Preglomerular Alterations During Angiotensin II Hypertension
Hypertension, December 1, 1997; 30(6): 1613 - 1620.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online